{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:33:15Z","timestamp":1762003995364},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Detection and Prevention"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.cdp.2007.01.001","type":"journal-article","created":{"date-parts":[[2007,4,7]],"date-time":"2007-04-07T11:17:04Z","timestamp":1175944624000},"page":"102-109","source":"Crossref","is-referenced-by-count":47,"title":["An investigation of relationships between hypoxia-inducible factor-1\u03b1 gene polymorphisms and ovarian, cervical and endometrial cancers"],"prefix":"10.1016","volume":"31","author":[{"given":"Ece","family":"Konac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ilke","family":"Onen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jale","family":"Metindir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"Alp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aydan Asyali","family":"Biri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Ekmekci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cdp.2007.01.001_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"10.1016\/j.cdp.2007.01.001_bib2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","article-title":"Purification and characterization of hypoxia-inducible factor 1","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.cdp.2007.01.001_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.cdp.2007.01.001_bib4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1525-1438.2005.00132.x","article-title":"Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets","volume":"15","author":"Rasila","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cdp.2007.01.001_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1","volume":"15","author":"Semenza","year":"1999","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"24","key":"10.1016\/j.cdp.2007.01.001_bib6","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.cdp.2007.01.001_bib7","first-page":"4010","article-title":"Hypoxia-inducible factor-1 alpha is a positive factor in solid tumor growth","volume":"60","author":"Ryan","year":"2000","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.cdp.2007.01.001_bib8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/82146","article-title":"Suppression of tumor growth through disruption of hypoxia-inducible transcription","volume":"6","author":"Kung","year":"2000","journal-title":"Nat Med"},{"issue":"22","key":"10.1016\/j.cdp.2007.01.001_bib9","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.cdp.2007.01.001_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jnci\/93.4.309","article-title":"Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis","volume":"93","author":"Bos","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.cdp.2007.01.001_bib11","first-page":"1830","article-title":"Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy","volume":"61","author":"Koukourakis","year":"2001","journal-title":"Cancer Res"},{"issue":"53","key":"10.1016\/j.cdp.2007.01.001_bib12","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/sj.onc.1203969","article-title":"Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis","volume":"19","author":"Saaristo","year":"2000","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.cdp.2007.01.001_bib13","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1210\/jc.2005-0991","article-title":"Genetic variation in the hypoxia-inducible factor-1 alpha gene is associated with type 2 diabetes in Japanese","volume":"90","author":"Yamada","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cdp.2007.01.001_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/bmme.1997.2627","article-title":"Sequence analysis of the 3\u2032 hypoxia-responsive element of the human erythropoietin gene in patients with erythrocytosis","volume":"62","author":"Percy","year":"1997","journal-title":"Biochem Mol Med"},{"issue":"11","key":"10.1016\/j.cdp.2007.01.001_bib15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/carcin\/bgg132","article-title":"Hypoxia-inducible factor-1 alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance","volume":"24","author":"Tanimoto","year":"2003","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.cdp.2007.01.001_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cancergencyto.2004.01.014","article-title":"Polymorphisms in the hypoxia inducible factor-1 alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype","volume":"153","author":"Ollerenshaw","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"issue":"11","key":"10.1016\/j.cdp.2007.01.001_bib17","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4161\/cbt.4.11.2091","article-title":"Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer","volume":"4","author":"Chau","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"10.1016\/j.cdp.2007.01.001_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-4598-5-3","article-title":"Hypoxia-inducible factor-1 alpha polymorphisms and TSC1\/2 mutations are complementary in head and neck cancers","volume":"16","author":"Hebert","year":"2006","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.cdp.2007.01.001_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1048-891X.2004.014514.x","article-title":"Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma","volume":"14","author":"Raspollini","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.cdp.2007.01.001_bib20","first-page":"1661","article-title":"Expression of hypoxia-inducible factor 1 alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy","volume":"7","author":"Birner","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.cdp.2007.01.001_bib21","first-page":"4693","article-title":"Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer","volume":"60","author":"Birner","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.cdp.2007.01.001_bib22","first-page":"19","article-title":"Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma","volume":"24","author":"Xiao","year":"2005","journal-title":"Ai Zheng"},{"issue":"23","key":"10.1016\/j.cdp.2007.01.001_bib23","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.cdp.2007.01.001_bib24","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1038\/sj.onc.1204602","article-title":"The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma","volume":"20","author":"Clifford","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cdp.2007.01.001_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1349-7006.2004.tb03196.x","article-title":"Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1\u03b1","volume":"95","author":"Kuwai","year":"2004","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.cdp.2007.01.001_bib26","first-page":"1033","article-title":"Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma","volume":"12","author":"Kuwai","year":"2004","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.cdp.2007.01.001_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/pros.20190","article-title":"Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation","volume":"63","author":"Fu","year":"2005","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.cdp.2007.01.001_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.canlet.2004.11.060","article-title":"Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study","volume":"225","author":"Kyzas","year":"2005","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.cdp.2007.01.001_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3835(01)00762-5","article-title":"Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma","volume":"176","author":"Nakayama","year":"2002","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.cdp.2007.01.001_bib30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0029-7844(99)00608-0","article-title":"Angiogenesis in early-invasive and low-malignant-potential epithelial ovarian carcinoma","volume":"95","author":"Abulafia","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cdp.2007.01.001_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(97)00350-9","article-title":"Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas","volume":"121","author":"Hartenbach","year":"1997","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.cdp.2007.01.001_bib32","first-page":"99","article-title":"The relationship between vascular endothelial growth factor -634 G>C polymorphism and ovarian, cervical and endometrial cancers","volume":"28","author":"Konac","year":"2006","journal-title":"Korean J Genetic"},{"issue":"4","key":"10.1016\/j.cdp.2007.01.001_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1443-9573.2005.00223.x","article-title":"Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma","volume":"6","author":"Ling","year":"2005","journal-title":"Chin J Dig Dis"},{"issue":"10","key":"10.1016\/j.cdp.2007.01.001_bib34","first-page":"838","article-title":"Angiogenesis-prognostic factor in patients with endometrial cancer","volume":"76","author":"Mazurek","year":"2005","journal-title":"Ginekol Pol"},{"issue":"30","key":"10.1016\/j.cdp.2007.01.001_bib35","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","article-title":"DNA binding, and transactivation properties of hypoxia-inducible factor 1","volume":"271","author":"Jiang","year":"1996","journal-title":"J Biol Chem"}],"container-title":["Cancer Detection and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361090X07000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361090X07000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T10:52:27Z","timestamp":1546944747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361090X07000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0361090X07000050"],"URL":"https:\/\/doi.org\/10.1016\/j.cdp.2007.01.001","relation":{},"ISSN":["0361-090X"],"issn-type":[{"value":"0361-090X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}